Several news agencies recently reported concerns of the FDA over the increased risk of Clostridium difficle diarrheal illness in patients using acid lowering antireflux drugs in the treatment of gastroesophageal reflux disease (GERD).
Dr. Starpoli recently lent his expertise to WebMD on the subject of PPI drugs. Read on:
Anthony A. Starpoli, MD | www.starpoli.com
